ARCHIVES

AGS-003 Immunotherapy Induces T Cell Responses in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA Deputy Commissioner Friedman Named Senior VP, Clinical Affairs, At G.D. Searle

June 16, 1999

NCI Seeks Health Care Provider Groups To Form Cancer Control Research Network

September 12, 1997

Breast Cancer: Pitt “Regrets” Any Harm, Expresses Pride In Fisher’s Work

September 5, 1997

Trials Approved by NCI CTEP For the Month of March

March 30, 2012

Interactive R01 Scores Vary widely, Result Of separate Review

June 11, 1993

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

June 16, 1999